Glycoprotein IIb/IIIa inhibitors in patients with unstable angina/non-ST-segment elevation myocardial infarction: Appropriate interpretation of the guidelines

被引：9
作者：
Antman, EM [1 ]
机构：
[1] Harvard Univ, Sch Med, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Samuel A Levine Cardiac Unit, Coronary Care Unit, Boston, MA 02115 USA
来源：
AMERICAN HEART JOURNAL | 2003年 / 146卷 / 04期
关键词：
D O I：
10.1016/j.ahj.2003.09.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
In 2002, the American College of Cardiology and the American Heart Association published an update to their guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. These revised guidelines make specific recommendations regarding the use of glycoprotein IIb/IIIa inhibitors. This article briefly reviews the evidence supporting the use of glycoprotein IIb/IIIa inhibitors in unstable angina and non-ST-segment elevation myocardial infarction, before moving on to discuss interpretation of these new guidelines.
引用
收藏
页数：5
相关论文
共 11 条
[1]   CD40L stabilizes arterial thrombi by a β3 integrin-dependent mechanism [J].
André, P ;
Prasad, KSS ;
Denis, CV ;
He, M ;
Papalia, JM ;
Hynes, RO ;
Phillips, DR ;
Wagner, DD .
NATURE MEDICINE, 2002, 8 (03) :247-252
[2]   'I can see clearly now': a new view on the use of IV GP IIb/IIIa inhibitors in acute coronary syndromes [J].
Antman, EM .
EUROPEAN HEART JOURNAL, 2002, 23 (18) :1408-1411
[3]   Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes -: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention [J].
Boersma, E ;
Akkerhuis, KM ;
Théroux, P ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
CIRCULATION, 1999, 100 (20) :2045-2048
[4]   Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials [J].
Boersma, E ;
Harrington, RA ;
Moliterno, DJ ;
White, H ;
Théroux, P ;
Van de Werf, F ;
de Torbal, A ;
Armstrong, PW ;
Wallentin, LC ;
Wilcox, RG ;
Simes, J ;
Califf, RM ;
Topol, EJ ;
Simoons, ML .
LANCET, 2002, 359 (9302) :189-198
[5]   Invasive versus conservative strategies in unstable angina and non-Q-wave myocardial infarction following treatment with tirofiban:: Rationale and study design of the international TACTICS-TIMI 18 trial [J].
Cannon, CP ;
Weintraub, WS ;
Demopoulos, LA ;
Robertson, DH ;
Gormley, GJ ;
Braunwald, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06) :731-736
[6]  
*COMM MAN PAT UNST, 2002, J AM COLL CARDIOL, V40, P1366
[7]   CD40 signaling in vascular cells:: A key role in atherosclerosis? [J].
Mach, F ;
Schönbeck, U ;
Libby, P .
ATHEROSCLEROSIS, 1998, 137 :S89-S95
[8]   Inhibitory effects of glycoprotein IIb/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation [J].
Nannizzi-Alaimo, L ;
Alves, VL ;
Phillips, DR .
CIRCULATION, 2003, 107 (08) :1123-1128
[9]   Platelet glycoprotein IIb/IIIa inhibitors - Recognition of a two-edged sword? [J].
Quinn, MJ ;
Plow, EF ;
Topol, EJ .
CIRCULATION, 2002, 106 (03) :379-385
[10]   Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes -: Gradient of benefit related to the revascularization strategy [J].
Roffi, M ;
Chew, DP ;
Mukherjee, D ;
Bhatt, DL ;
White, JA ;
Moliterno, DJ ;
Heeschen, C ;
Hamm, CW ;
Robbins, MA ;
Kleiman, NS ;
Théroux, P ;
White, HD ;
Topol, EJ .
EUROPEAN HEART JOURNAL, 2002, 23 (18) :1441-1448
12